These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 23445751

  • 1. Inhaled corticosteroids and the increased risk of pneumonia.
    Marzoratti L, Iannella HA, Waterer GW.
    Ther Adv Respir Dis; 2013 Aug; 7(4):225-34. PubMed ID: 23445751
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M, Du Y, Chen H, Jiang D, Xu Z.
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [Abstract] [Full Text] [Related]

  • 3. Systemic effects of inhaled corticosteroids.
    Ernst P, Suissa S.
    Curr Opin Pulm Med; 2012 Jan; 18(1):85-9. PubMed ID: 22112998
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association.
    Singanayagam A, Chalmers JD, Hill AT.
    QJM; 2010 Jun; 103(6):379-85. PubMed ID: 20231237
    [Abstract] [Full Text] [Related]

  • 5. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
    Antón E.
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):25-32. PubMed ID: 23551021
    [Abstract] [Full Text] [Related]

  • 6. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S, Amin AV, Loke YK.
    Arch Intern Med; 2009 Feb 09; 169(3):219-29. PubMed ID: 19204211
    [Abstract] [Full Text] [Related]

  • 7. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
    Festic E, Scanlon PD.
    Am J Respir Crit Care Med; 2015 Jan 15; 191(2):141-8. PubMed ID: 25409118
    [Abstract] [Full Text] [Related]

  • 8. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, Carlsson LG, Sin DD.
    Respir Med; 2012 Nov 15; 106(11):1487-93. PubMed ID: 22902134
    [Abstract] [Full Text] [Related]

  • 9. The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.
    Andreeva-Gateva PA, Stamenova E, Gatev T.
    Postgrad Med; 2016 Jun 15; 128(5):474-84. PubMed ID: 27153510
    [Abstract] [Full Text] [Related]

  • 10. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC, Hurst MM.
    Pharmacol Ther; 2011 May 15; 130(2):114-43. PubMed ID: 21276815
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ.
    Respiration; 2010 May 15; 80(2):89-95. PubMed ID: 20501985
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec 15; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 13. Inhaled corticosteroids for chronic obstructive pulmonary disease.
    Cazzola M, Rogliani P, Novelli L, Matera MG.
    Expert Opin Pharmacother; 2013 Dec 15; 14(18):2489-99. PubMed ID: 24138334
    [Abstract] [Full Text] [Related]

  • 14. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):589-95. PubMed ID: 20889908
    [Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 01; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 17. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Chen H, Feng Y, Wang K, Yang J, Du Y.
    BMC Pulm Med; 2020 Oct 28; 20(1):282. PubMed ID: 33115481
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG, Powell H, Ducharme FM.
    J Allergy Clin Immunol; 2007 Feb 28; 119(2):344-50. PubMed ID: 17291852
    [Abstract] [Full Text] [Related]

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 28; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 20. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
    Chen H, Deng ZX, Sun J, Huang Q, Huang L, He YH, Ma C, Wang K.
    Chest; 2023 Jan 28; 163(1):100-114. PubMed ID: 35921883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.